Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesDynamic Model for Predicting Death Within 12 Months in Patients With Primary or Post-Polycythemia Vera/Essential Thrombocythemia Myelofibrosis
Journal of Clinical Oncology, 10/05/09
Tam CS et al. – Blood or bone marrow blasts >=10%, platelets less than 50 x 109/L, and chromosome 17 aberrations defined AP in patients with MF. Patients in AP should be candidates for intensive therapeutic interventions.
Related Articles
Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera
Journal of Clinical Oncology, 10/16/09
Relevance Score: 64%
Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera
Cancer, 10/08/09
Relevance Score: 64%
Insights into the pathogenesis and management of thrombosis in polycythemia vera and essential thrombocythemia
Internal and Emergency Medicine, 10/06/09
Relevance Score: 64%
Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets
European Journal of Endocrinology, 11/17/09
Relevance Score: 42%
Vitamin D deficiency and anemia: a cross-sectional study
Annals of Hematology, 10/26/09
Relevance Score: 40%
Today in Myeloproliferative Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
The proteasome inhibitor CEP-18770 enhances the anti-myeloma activity of bortezomib and melphalan
British Journal of Haematology, 12/11/09
Inhibitory effect of baicalein on IL-6-mediated signaling cascades in human myeloma cells
European Journal of Haematology, 12/11/09
The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome
Blood, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor